About this blog

Case Disclosed is a blog written by students, supervising attorneys, directors, alumni, and friends of the Media Freedom & Information Access Clinic.

The views expressed on this blog belong to the author(s) and do not represent the views of Yale Law School or the Media Freedom and Information Access Clinic (MFIA).

[title_1]

Transparency organizations raise concerns about Uniform Law Commission’s redaction initiative
June 19, 2022
Save the dates for the 2022 FOI Summit, and watch this space for updates
June 3, 2022
NFOIC FOI Research Competition deadline extended to May 20
May 4, 2022
NFOIC begins transfer of admin duties to Virginia coalition, renews focus on members
April 26, 2022

View more

Tags

Administrative Law
Internet Intermediaries
Net Neutrality
transparency
Privacy and Surveillance
Newsgathering
Government Accountability
Censorship
Government Transparency
CRIT
International Law
Information Fiduciaries
Secrecy
Open Records
Law Enforcement
Constitutional Access
Public Forums
Free Speech
Mass Surveillance
FOIA
Technology
Open Data
First Amendment
MFIA Docket
First Amendment Right of Access
Fourth Estate
reporter's privilege
National Security
Online Speech
Right to Petition
Free Press
Social Media
Free Expression
Internet Infrastructure

Case Disclosed

The Booming Market for Apocalyptic Literature

March 27, 2017
By Andrew Udelsman

Few so accurately predicted the era of “alternative facts” than Orwell, who had this to say: “He who controls the past controls the future. He who controls the present controls the past.”

Read more

Prospective Injunctions Under FOIA

March 9, 2017
By Yurij Melynk

Even for its strongest advocates and those who regularly exercise the rights it grants, the Freedom of Information Act is often reduced to its most-invoked provision: the obligation of federal agencies to produce specific records in response to requests.

Read more

The President and the Press: A Very Dangerous Precedent?

February 21, 2017
By Regina Wang

Several news outlets have spoken out about President Trump for calling on only conservative and conservative leaning news outlets in three joint news conferences with foreign leaders over the last few weeks.

Read more

The Risks of Trump's Proposal to Speed Up Drug Approvals

February 20, 2017
By Mark Doré

President Trump has signaled—often and recently—that he believes drug approval moves too slowly. Meeting with drug manufacturers at the White House on Jan. 31, Trump promised quick yes-or-no approval decisions on new drugs (and stressed the need for lower prices and U.S.-based manufacturing).

Read more

Pages